EuroAPI Header EuroAPI Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Biogen aggregated by PharmaCompass.com.

    Client Virtual Booth

    BIOGEN

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Biogen
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    225 Binney Street Cambridge, MA 02142
    Telephone
    Telephone
    +1 781-464-2000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biogen.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/biogen-/
    Twitter
    Twitter
    https://twitter.com/biogen

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    BioArctic Comments On Lecanemab Approval Rumors In Britain
    BioArctic Comments On Lecanemab Approval Rumors In Britain

    https://www.prnewswire.com/news-releases/regarding-rumors-of-an-imminent-approval-of-lecanemab-in-great-britain-bioarctic-302228382.html

    PR NEWSWIRE
    22 Aug 2024
    Share Share
    New Alzheimer's drug deemed too costly for UK's state-run health service
    New Alzheimer's drug deemed too costly for UK's state-run health service

    https://www.reuters.com/business/healthcare-pharmaceuticals/uk-patients-unlikely-get-access-eisai-biogens-alzheimers-drug-2024-08-22/

    REUTERS
    22 Aug 2024
    Share Share
    Biogen Sued Over Alleged PBM Kickbacks For Tecfidera
    Biogen Sued Over Alleged PBM Kickbacks For Tecfidera

    https://www.fiercepharma.com/pharma/biogen-sued-alleged-pbm-kickbacks-scheme-boost-tecfidera-sales-wake-generic-competition

    FIERCE PHARMA
    21 Aug 2024
    Share Share
    Incyte's blood cancer drug succeeds late-stage trial
    Incyte's blood cancer drug succeeds late-stage trial

    https://www.reuters.com/business/healthcare-pharmaceuticals/incytes-blood-cancer-drug-succeeds-late-stage-trial-2024-08-15/

    REUTERS
    16 Aug 2024
    Share Share
    Metagenomi axes ALS program after seeing Biogen and Ionis flounder
    Metagenomi axes ALS program after seeing Biogen and Ionis flounder

    https://www.fiercebiotech.com/biotech/metagenomi-axes-als-program-after-seeing-biogen-and-ionis-flounder

    FIERCE BIOTECH
    14 Aug 2024
    Share Share
    Immunic Reports Q2 2024 Results And Provides Corporate Update
    Immunic Reports Q2 2024 Results And Provides Corporate Update

    https://www.prnewswire.com/news-releases/immunic-inc-reports-second-quarter-2024-financial-results-and-provides-corporate-update-302216567.html

    PR NEWSWIRE
    08 Aug 2024
    Share Share
    Sangamo secures $50M upfront in neurodegenerative pact with Roche's Genentech
    Sangamo secures $50M upfront in neurodegenerative pact with Roche's Genentech

    https://www.fiercebiotech.com/biotech/sangamo-secures-50m-upfront-neurodegenerative-pact-genentech

    FEIRCE BIOTECH
    07 Aug 2024
    Share Share
    Sangamo secures $50M upfront in neurodegenerative pact with Roche's Genentech
    Sangamo secures $50M upfront in neurodegenerative pact with Roche's Genentech

    https://www.fiercebiotech.com/biotech/sangamo-secures-50m-upfront-neurodegenerative-pact-genentech

    FIERCE BIOTECH
    06 Aug 2024
    Share Share
    Biogen Keeps Biosimilars As Leqembi Advances Amid Business Shift
    Biogen Keeps Biosimilars As Leqembi Advances Amid Business Shift

    https://www.fiercepharma.com/pharma/biogen-retains-biosimilars-eisai-partnered-leqembi-ploughs-ahead-amid-business-pivot

    FIERCE PHARMA
    02 Aug 2024
    Share Share
    Biogen lifts profit forecast, signals progress in turnaround effort
    Biogen lifts profit forecast, signals progress in turnaround effort

    https://www.reuters.com/business/healthcare-pharmaceuticals/biogen-lifts-2024-profit-forecast-hopes-new-product-launches-2024-08-01/

    REUTERS
    01 Aug 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    aspen-api-m-2024-08-19

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search